Resources from the same session
Targeting KRAS beyond G12C – what is coming?
Presenter: H. R. Kim, KR
Session: Session 3 – Moving beyond KRAS G12C
Resources:
Slides
Webcast
Vaccine and adoptive cell therapy strategies for the treatment of KRAS mutant NSCLC
Presenter: M. Nagasaka, US
Session: Session 3 – Moving beyond KRAS G12C
Resources:
Slides
Webcast